Robecosam AG trimmed its position in shares of Xylem Inc (NYSE:XYL) by 10.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 512,397 shares of the industrial products company’s stock after selling 58,797 shares during the quarter. Xylem accounts for approximately 2.3% of Robecosam AG’s portfolio, making the stock its 6th largest holding. Robecosam AG owned about 0.29% of Xylem worth $34,971,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of XYL. Greenleaf Trust grew its position in Xylem by 97.4% during the fourth quarter. Greenleaf Trust now owns 1,490 shares of the industrial products company’s stock worth $102,000 after buying an additional 735 shares during the period. Invictus RG acquired a new position in Xylem during the third quarter worth about $104,000. Hanson & Doremus Investment Management acquired a new position in Xylem during the fourth quarter worth about $126,000. FNY Partners Fund LP grew its position in Xylem by 2,700.0% during the third quarter. FNY Partners Fund LP now owns 2,800 shares of the industrial products company’s stock worth $175,000 after buying an additional 2,700 shares during the period. Finally, UMB Bank N A MO acquired a new position in Xylem during the fourth quarter worth about $205,000. Institutional investors and hedge funds own 85.46% of the company’s stock.
Shares of Xylem Inc (NYSE:XYL) opened at $79.48 on Monday. Xylem Inc has a fifty-two week low of $47.73 and a fifty-two week high of $79.52. The stock has a market cap of $14,297.90, a PE ratio of 33.26, a price-to-earnings-growth ratio of 1.53 and a beta of 1.12. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.88 and a quick ratio of 1.41.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 15th. Shareholders of record on Thursday, February 15th will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 1.06%. The ex-dividend date of this dividend is Wednesday, February 14th. This is an increase from Xylem’s previous quarterly dividend of $0.18. Xylem’s dividend payout ratio is 45.65%.
Several brokerages have weighed in on XYL. Cowen restated a “buy” rating and set a $80.00 target price on shares of Xylem in a research report on Tuesday, March 6th. ValuEngine upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Thursday, March 1st. Zacks Investment Research lowered shares of Xylem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 13th. BMO Capital Markets restated a “buy” rating and set a $86.00 target price on shares of Xylem in a research report on Friday, February 2nd. Finally, Seaport Global Securities restated a “buy” rating and set a $83.00 target price on shares of Xylem in a research report on Friday, February 2nd. Five analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Xylem currently has an average rating of “Buy” and a consensus target price of $72.42.
In other Xylem news, Director Steven R. Loranger sold 47,712 shares of the company’s stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $68.10, for a total value of $3,249,187.20. Following the sale, the director now owns 68,843 shares of the company’s stock, valued at $4,688,208.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Curtis J. Crawford sold 7,948 shares of the company’s stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $71.77, for a total transaction of $570,427.96. Following the completion of the sale, the director now directly owns 55,245 shares in the company, valued at approximately $3,964,933.65. The disclosure for this sale can be found here. Insiders sold 88,416 shares of company stock worth $6,123,979 in the last ninety days. Insiders own 0.75% of the company’s stock.
WARNING: “Robecosam AG Sells 58,797 Shares of Xylem Inc (XYL)” was first posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/03/12/robecosam-ag-sells-58797-shares-of-xylem-inc-xyl.html.
Xylem Inc is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.